Noveome Biotherapeutics, Inc. Announces New Appointments to Board of Directors

PITTSBURGH--(BUSINESS WIRE)--Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed Eric Keller, J.D. and Houman D. Hemmati, M.D., Ph.D. to the company’s Board of Directors. Eric Keller is a proven business and legal executive with nearly 30 years of experience in life sciences-based companies. He is Founder and CEO of Redux Therapeutics, LLC, a clinical